Infection, Immunity and Vaccines

Date:	November 16, 2017   |   9:00 am – 5:00 pm November 17, 2017   |   9:00 am – 3:00 pm
Location:	The Menger Hotel 204 Alamo Plaza San Antonio, TX 78205

---

Registration TBD	Poster Requirements » Poster size: 36″ x 36″ or 36″ x 48″ or 36″ x 54″ » Must have at least two (2) authors » Abstract limited to 250 words maximum » May use either results or methodology
Abstract Deadline: TBD
Registration Deadline: TBD
Accommodations TBD

---

 

Keynote Speakers

TBD

Dr. William Bishai, Professor and Co-Director, Center for Tuberculosis Research, Johns Hopkins School of Medicine

Dr. Bishai is interested in the molecular pathogenesis of tuberculosis. A theme of his research has been to assess mycobacterial genes important in gene regulation. Other active interests include cell division in mycobacteria and the pathogenesis of caseation and cavitation. His research program goals are first to better understand tuberculosis pathogenesis, and then to employ this understanding towards improved drugs, vaccines, and diagnostics.

Dr. Bishai received his Ph.D. and his M.D. from Harvard Medical School.

 

TBD

Dr. Michel Nussenzweig, Zanvil A Cohn and Ralph M Steinman Professor and Investigator, Howard Hughes Medical Institute, The Rockefeller University

The focus of the Nussenzweig laboratory is to understand the development of effective antibody responses with the ultimate goal of learning how to elicit vaccine responses against complex pathogens such as HIV-1. These responses require production of a diverse collection of B-lymphocytes expressing non-self reactive antibodies and their activation by T cells, which are in turn activated by antigen presenting dendritic cells (DCs).

Dr. Nussenzweig received his Ph.D. from The Rockefeller University and his M.D. from New York University Medical School.

 

TBD

Dr. Connie Schmaljohn, Senior Research Scientist, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)

An internationally recognized expert on hantaviruses and hemorrhagic fever with renal syndrome, Dr. Schmaljohn uses molecular biology tools to develop and test vaccines for a range of viruses. Her lab works on two types of vaccines: those that protect against medical infectious diseases and those that defend against agents that could be used as weapons in biological warfare.

Dr. Schmaljohn received her Ph.D. from Colorado State University.

 

How Gut Microbiota Impact Gut-distal Autoimmune Disease

Dr. Hsin-Jung Joyce Wu, Assistant Professor, Department of Immunobiology, The University of Arizona College of Medicine

Dr. Wu’s current research includes dysregulation of immunity and inflammation, Immunotherapy and immune intervention, and microbial pathogenesis and commensalism. These research areas are dedicated to the understanding of how commensal bacteria influence the inflammatory and immune response mediated by autoimmune disease. The goal of this work is focused on exploring the link between gut microbiota, mucosal immunity, and autoimmune arthritis.

Dr. Wu received her Ph.D. from the University of Kentucky.